Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2006

Open Access 01-12-2006 | Research article

Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease

Authors: Gokul Krishnan, Brydon J Grant, Paola C Muti, Archana Mishra, Heather M Ochs-Balcom, Jo L Freudenheim, Maurizio Trevisan, Holger J Schünemann

Published in: BMC Pulmonary Medicine | Issue 1/2006

Login to get access

Abstract

Background

Several studies investigated the association of anemia with health related quality of life (HRQL) in patients with chronic disease. However, there is little evidence regarding the association of anemia with HRQL in patients with chronic obstructive pulmonary disease (COPD).

Methods

This is a post-hoc analysis of a study which enrolled a population of adults aged 35–79 randomly selected from residents of Erie and Niagara Counties, NY, between 1996 and 2000. In addition to demographic information and physical measurements, we obtained spirometry data and hemoglobin levels. We used modified Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria to define COPD, and World Health Organization (WHO) criteria to define anemia. To assess HRQL we used the Short Form-36 (SF-36) to assess physical functioning (PF), physical component summary (PCS) measures and mental component summary (MCS) measures.

Results

In the entire study population (n = 2704), respondents with anemia had lower scores on the physical functioning domain [45.4 (SD10.9) vs. 49.2 (SD 9.1); p < 0.0001]. Among patients with COPD (n = 495) the PF scores (39.9 vs. 45.4) and the PCS (41.9 vs. 45.9) were significantly lower in individuals with anemia compared to those without. In multiple regression analysis, the association between hemoglobin and PCS was positive (regression coefficient 0.02, p = 0.003). There was no significant association of hemoglobin with PF scores or the mental component summary measure after adjusting for covariates in patients with COPD.

Conclusion

In patients with moderate to very severe COPD anemia may be associated with worse HRQL. However, co-morbidities may explain part or all of this association in these patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mahler DA, Jones PW: Measurement of dyspnea and quality of life in advanced lung disease. Clin Chest Med. 1997, 18 (3): 457-469. 10.1016/S0272-5231(05)70394-4.CrossRefPubMed Mahler DA, Jones PW: Measurement of dyspnea and quality of life in advanced lung disease. Clin Chest Med. 1997, 18 (3): 457-469. 10.1016/S0272-5231(05)70394-4.CrossRefPubMed
2.
go back to reference Theander K, Unosson M: Fatigue in patients with chronic obstructive pulmonary disease. J Adv Nurs. 2004, 45 (2): 172-177. 10.1046/j.1365-2648.2003.02878.x.CrossRefPubMed Theander K, Unosson M: Fatigue in patients with chronic obstructive pulmonary disease. J Adv Nurs. 2004, 45 (2): 172-177. 10.1046/j.1365-2648.2003.02878.x.CrossRefPubMed
3.
go back to reference Sobrero A, Puglisi F, Guglielmi A, Belvedere O, Aprile G, Ramello M, Grossi F: Fatigue: a main component of anemia symptomatology. Semin Oncol. 2001, 28 (2 Suppl 8): 15-18. 10.1016/S0093-7754(01)90207-6.CrossRefPubMed Sobrero A, Puglisi F, Guglielmi A, Belvedere O, Aprile G, Ramello M, Grossi F: Fatigue: a main component of anemia symptomatology. Semin Oncol. 2001, 28 (2 Suppl 8): 15-18. 10.1016/S0093-7754(01)90207-6.CrossRefPubMed
4.
go back to reference Cella D: The effects of anemia and anemia treatment on the quality of life of people with cancer. Oncology (Huntingt). 2002, 16 (9 Suppl 10): 125-132. Cella D: The effects of anemia and anemia treatment on the quality of life of people with cancer. Oncology (Huntingt). 2002, 16 (9 Suppl 10): 125-132.
5.
go back to reference Gregory N: Effect of higher hemoglobin levels on health-related quality of life parameters. Nephrol Nurs J. 2003, 30 (1): 75-78.PubMed Gregory N: Effect of higher hemoglobin levels on health-related quality of life parameters. Nephrol Nurs J. 2003, 30 (1): 75-78.PubMed
6.
go back to reference Cella D, Dobrez D, Glaspy J: Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes. Ann Oncol. 2003, 14 (4): 511-519. 10.1093/annonc/mdg167.CrossRefPubMed Cella D, Dobrez D, Glaspy J: Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes. Ann Oncol. 2003, 14 (4): 511-519. 10.1093/annonc/mdg167.CrossRefPubMed
7.
go back to reference Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S: Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol. 1997, 15 (3): 1218-1234.PubMed Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S: Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol. 1997, 15 (3): 1218-1234.PubMed
8.
go back to reference Moreno F, Sanz-Guajardo D, Lopez-Gomez JM, Jofre R, Valderrabano F: Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. J Am Soc Nephrol. 2000, 11 (2): 335-342.PubMed Moreno F, Sanz-Guajardo D, Lopez-Gomez JM, Jofre R, Valderrabano F: Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. J Am Soc Nephrol. 2000, 11 (2): 335-342.PubMed
9.
go back to reference Henke M, Laszig R, Rube C, Schafer U, Haase KD, Schilcher B, Mose S, Beer KT, Burger U, Dougherty C, Frommhold H: Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet. 2003, 362 (9392): 1255-1260. 10.1016/S0140-6736(03)14567-9.CrossRefPubMed Henke M, Laszig R, Rube C, Schafer U, Haase KD, Schilcher B, Mose S, Beer KT, Burger U, Dougherty C, Frommhold H: Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet. 2003, 362 (9392): 1255-1260. 10.1016/S0140-6736(03)14567-9.CrossRefPubMed
10.
go back to reference Stanbrook MB: The prevalence of anemia in chronic obstructive pulmonary disease [abstract]. Am J Respir Crit Care Med. 2003, 167: A235- Stanbrook MB: The prevalence of anemia in chronic obstructive pulmonary disease [abstract]. Am J Respir Crit Care Med. 2003, 167: A235-
11.
go back to reference Park MM, Durrani M, Zilberberg M: Correlation of severity of anemia with severity of COPD [abstract]. Am J Respir Crit Care Med. 2003, 167: A234- Park MM, Durrani M, Zilberberg M: Correlation of severity of anemia with severity of COPD [abstract]. Am J Respir Crit Care Med. 2003, 167: A234-
12.
go back to reference John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD: Anemia and inflammation in COPD. Chest. 2005, 127 (3): 825-829. 10.1378/chest.127.3.825.CrossRefPubMed John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD: Anemia and inflammation in COPD. Chest. 2005, 127 (3): 825-829. 10.1378/chest.127.3.825.CrossRefPubMed
13.
go back to reference Schunemann HJ, Grant BJ, Freudenheim JL, Muti P, Browne RW, Drake JA, Klocke RA, Trevisan M: The relation of serum levels of antioxidant vitamins C and E, retinol and carotenoids with pulmonary function in the general population. Am J Respir Crit Care Med. 2001, 163 (5): 1246-1255.CrossRefPubMed Schunemann HJ, Grant BJ, Freudenheim JL, Muti P, Browne RW, Drake JA, Klocke RA, Trevisan M: The relation of serum levels of antioxidant vitamins C and E, retinol and carotenoids with pulmonary function in the general population. Am J Respir Crit Care Med. 2001, 163 (5): 1246-1255.CrossRefPubMed
14.
go back to reference de Haan RJ: Measuring quality of life after stroke using the SF-36. Stroke. 2002, 33 (5): 1176-1177. 10.1161/01.STR.0000015223.98452.97.CrossRefPubMed de Haan RJ: Measuring quality of life after stroke using the SF-36. Stroke. 2002, 33 (5): 1176-1177. 10.1161/01.STR.0000015223.98452.97.CrossRefPubMed
15.
go back to reference Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995, 152 (3): 1107-1136. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995, 152 (3): 1107-1136.
16.
go back to reference Hurd S, Pauwels R: Global Initiative for Chronic Obstructive Lung Diseases (GOLD). Pulm Pharmacol Ther. 2002, 15 (4): 353-355. 10.1006/pupt.2002.0381.CrossRefPubMed Hurd S, Pauwels R: Global Initiative for Chronic Obstructive Lung Diseases (GOLD). Pulm Pharmacol Ther. 2002, 15 (4): 353-355. 10.1006/pupt.2002.0381.CrossRefPubMed
17.
go back to reference Haywood KL, Garratt AM, Fitzpatrick R: Quality of life in older people: a structured review of generic self-assessed health instruments. Qual Life Res. 2005, 14 (7): 1651-1668. 10.1007/s11136-005-1743-0.CrossRefPubMed Haywood KL, Garratt AM, Fitzpatrick R: Quality of life in older people: a structured review of generic self-assessed health instruments. Qual Life Res. 2005, 14 (7): 1651-1668. 10.1007/s11136-005-1743-0.CrossRefPubMed
18.
go back to reference SF-36 Health Survey Manual and Interpretation Guide. 2003, QualityMetric Incorporated SF-36 Health Survey Manual and Interpretation Guide. 2003, QualityMetric Incorporated
19.
go back to reference Iron Deficiency Anemia. Assessment, Prevention, and Control. A guide for programme managers. 2001, World Health Organization, WHO/NHD/01.3: Iron Deficiency Anemia. Assessment, Prevention, and Control. A guide for programme managers. 2001, World Health Organization, WHO/NHD/01.3:
20.
go back to reference Stromberg A, Martensson J: Gender differences in patients with heart failure. Eur J Cardiovasc Nurs. 2003, 2 (1): 7-18. 10.1016/S1474-5151(03)00002-1.CrossRefPubMed Stromberg A, Martensson J: Gender differences in patients with heart failure. Eur J Cardiovasc Nurs. 2003, 2 (1): 7-18. 10.1016/S1474-5151(03)00002-1.CrossRefPubMed
21.
go back to reference van Jaarsveld CH, Sanderman R, Ranchor AV, Ormel J, van Veldhuisen DJ, Kempen GI: Gender-specific changes in quality of life following cardiovascular disease: a prospective study. J Clin Epidemiol. 2002, 55 (11): 1105-1112. 10.1016/S0895-4356(02)00506-1.CrossRefPubMed van Jaarsveld CH, Sanderman R, Ranchor AV, Ormel J, van Veldhuisen DJ, Kempen GI: Gender-specific changes in quality of life following cardiovascular disease: a prospective study. J Clin Epidemiol. 2002, 55 (11): 1105-1112. 10.1016/S0895-4356(02)00506-1.CrossRefPubMed
22.
go back to reference Wood RH, Gardner RE, Ferachi KA, King C, Ermolao A, Cherry KE, Cress ME, Jazwinski SM: Physical function and quality of life in older adults: sex differences. South Med J. 2005, 98 (5): 504-512. 10.1097/01.SMJ.0000157534.08859.4B.CrossRefPubMed Wood RH, Gardner RE, Ferachi KA, King C, Ermolao A, Cherry KE, Cress ME, Jazwinski SM: Physical function and quality of life in older adults: sex differences. South Med J. 2005, 98 (5): 504-512. 10.1097/01.SMJ.0000157534.08859.4B.CrossRefPubMed
23.
go back to reference Koch CG, Khandwala F, Cywinski JB, Ishwaran H, Estafanous FG, Loop FD, Blackstone EH: Health-related quality of life after coronary artery bypass grafting: a gender analysis using the Duke Activity Status Index. J Thorac Cardiovasc Surg. 2004, 128 (2): 284-295. 10.1016/j.jtcvs.2003.12.033.CrossRefPubMed Koch CG, Khandwala F, Cywinski JB, Ishwaran H, Estafanous FG, Loop FD, Blackstone EH: Health-related quality of life after coronary artery bypass grafting: a gender analysis using the Duke Activity Status Index. J Thorac Cardiovasc Surg. 2004, 128 (2): 284-295. 10.1016/j.jtcvs.2003.12.033.CrossRefPubMed
24.
go back to reference de Korte J, Sprangers MA, Mombers FM, Bos JD: Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc. 2004, 9 (2): 140-147. 10.1046/j.1087-0024.2003.09110.x.CrossRefPubMed de Korte J, Sprangers MA, Mombers FM, Bos JD: Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc. 2004, 9 (2): 140-147. 10.1046/j.1087-0024.2003.09110.x.CrossRefPubMed
25.
go back to reference Ishani A, Weinhandl E, Zhao Z, Gilbertson DT, Collins AJ, Yusuf S, Herzog CA: Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2005, 45 (3): 391-399. 10.1016/j.jacc.2004.10.038.CrossRefPubMed Ishani A, Weinhandl E, Zhao Z, Gilbertson DT, Collins AJ, Yusuf S, Herzog CA: Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2005, 45 (3): 391-399. 10.1016/j.jacc.2004.10.038.CrossRefPubMed
26.
go back to reference Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW: A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987, 42 (10): 773-778.CrossRefPubMedPubMedCentral Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW: A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987, 42 (10): 773-778.CrossRefPubMedPubMedCentral
27.
go back to reference Schünemann HJ, Goldstein R, Mador MJ, McKim D, Stahl E, Puhan M, Griffith LE, Grant B, Austin P, Collins R, et al: A randomized controlled trial to evaluate the self-administered standardized CRQ. Eur Respir J. 2005, 25 (1): 31-40. 10.1183/09031936.04.00029704.CrossRefPubMed Schünemann HJ, Goldstein R, Mador MJ, McKim D, Stahl E, Puhan M, Griffith LE, Grant B, Austin P, Collins R, et al: A randomized controlled trial to evaluate the self-administered standardized CRQ. Eur Respir J. 2005, 25 (1): 31-40. 10.1183/09031936.04.00029704.CrossRefPubMed
28.
go back to reference Jones PW, Quirk FH, Baveystock CM: The St George's Respiratory Questionnaire. Respir Med. 1991, 85 Suppl B: 25-31; discussion 33-7.CrossRefPubMed Jones PW, Quirk FH, Baveystock CM: The St George's Respiratory Questionnaire. Respir Med. 1991, 85 Suppl B: 25-31; discussion 33-7.CrossRefPubMed
29.
go back to reference Harper R, Brazier JE, Waterhouse JC, Walters SJ, Jones NM, Howard P: Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax. 1997, 52 (10): 879-887.CrossRefPubMedPubMedCentral Harper R, Brazier JE, Waterhouse JC, Walters SJ, Jones NM, Howard P: Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax. 1997, 52 (10): 879-887.CrossRefPubMedPubMedCentral
Metadata
Title
Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease
Authors
Gokul Krishnan
Brydon J Grant
Paola C Muti
Archana Mishra
Heather M Ochs-Balcom
Jo L Freudenheim
Maurizio Trevisan
Holger J Schünemann
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2006
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-6-23

Other articles of this Issue 1/2006

BMC Pulmonary Medicine 1/2006 Go to the issue